Inter‐alpha‐trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis

OBJECTIVE: Inter‐alpha‐trypsin inhibitor heavy chain 4 (ITIH4) regulates immunity and inflammation, but its clinical role in rheumatoid arthritis (RA) patients remains unclear. Hence, this study was conducted to explore the association of circulating ITIH4 with disease risk, clinical features, infla...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kejian, He, Sanshan, Su, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906037/
https://www.ncbi.nlm.nih.gov/pubmed/35064701
http://dx.doi.org/10.1002/jcla.24231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906037/
https://www.ncbi.nlm.nih.gov/pubmed/35064701
http://dx.doi.org/10.1002/jcla.24231

Ejemplares similares